Texas A&M team wins second round of Boeing-backed flight device competition

Prepare for takeoff

A team out of Texas A&M University is a finalist for Boeing's GoFly competition. Courtesy of GoFly

A team from Texas A&M University has advanced in a global Boeing-sponsored competition called GoFly. The competition asks teams to create a personal flying device aircraft that is smaller, lighter, and quieter than any currently existing model.

Texas A&M Harmony is one of the five teams named a winner in GoFly's Phase II competition, which has more than 3,500 innovators from 101 countries across the world. The teams are now preparing for the Final Fly-Off expected to take place in 2020, at which point innovators will put their aircrafts to the test, competing at a final event showcase and for the remaining $1.6 million in prizes.

Dr. Moble Benedict leads the team and is an assistant professor of aerospace engineering at TAMU and founder of the Advanced Vertical Flight Laboratory with 15 years of experience in vertical take-off and landing aircraft concepts. Texas A&M Harmony is the only team from Texas currently in the competition.

"The first time I heard about the GoFly competition, I thought 'this is impossible I can't do it,'" says Moble Benedict, Harmony's team captain and an assistant professor of aerospace engineering at TAMU.

Benedict, who also founded the Advanced Vertical Flight Laboratory with 15 years of experience in vertical take-off and landing aircraft concepts, proposed the competition to his students and his connections in the field to build his current team.

"The first few months we spent brainstorming different ideas," Benedict tells InnovationMap.

The team created a design called Aria, which was inspired by the word's musical roots.

"Being engineers, we were trying to stick with a theme," says Carl Runco, a PhD student at the Advanced Vertical Flight Lab of TAMU. "We struck on 'Aria,' and thought 'that's it' because Aria is the solo of an opera and we're designing a single-person vehicle."

Aria is a high technology readiness level compact rotorcraft designed to minimize noise and maximize efficiency, safety, reliability, and flight experience, according to the GoFly website.

"The key outcome of this design is the rotor system we have designed," says Benedict. "We have come up with a very unique rotor system which is very quiet without compromising the efficiency. That's something very hard to do."

In addition to Benedict and Runco, the Harmony team has a total of 12 members — from PhDs to professors, including:

  • David Coleman, a PhD student conducting research at AVFL (Advanced Vertical Flight Laboratory)
  • Hunter Denton, a Masters student in AVFL at TAMU
  • Dr. Eric Greenwood, who received a PhD in Aerospace Engineering from the University of Maryland and is a researcher at NASA Langley developing rotor noise modeling methods and experimental techniques
  • Atanu Halder, a PhD candidate in Aerospace Engineering at TAMU
  • Dr. Vikram Hrishikeshavan, an Assistant Research Scientist at the University of Maryland with 14 years of experience in VTOL aircraft concepts
  • Dr. Vinod Lakshminarayan, a Research Scientist at Science and Technology Corporation, NASA Ames Research Center
  • Bochan Lee, a South Korean Navy UH-60 pilot and a current graduate researcher at AVFL
  • Farid Saemi, a PhD student at TAMU
  • Vishaal Subramanian, a Masters student at the Aerospace department of TAMU
  • Aswathi Sudhir, a PhD student in Materials and Structures from Aerospace department of TAMU.

Winning the competition would put the Texas university on the map for aerospace engineering.

"The recognition would be invaluable," says Saemi.

The GoFly competition is broken up into three phases that began in 2017 according to the website. The first phase focused on written reports detailing each team's design and plan. After advancing through that round, Harmony entered Phase II, which included a re-review of Phase I materials and a demonstration of the progress each team has made. The five winners of Phase II will compete in a fly-off in 2020.

Other teams based in the United States include Trek Aerospace FK2 Inc. and DragonAir Aviation. International teams include Silverwing Personal Flight, from the Netherlands, and Aeroxo LV, from Latvia and Russia.

"We're inspired and excited to see the strong progress that GoFly competitors have made on their bold, creative designs," says Greg Hyslop, Boeing's CTO, in the press release. "Their work confirms a principle that's at the core of both Boeing and GoFly: aerospace innovation changes the world."

While the team is focused on next year's fly-off competition, they see the potential for a company taking off.

"If we're successful enough and attract enough attention, there is definitely interest in turning the team into an official company," says Runco. "We want to be able to sell these things."

Texas A&M Harmony has 12 team members and is advancing to the final round of the competition. Courtesy of GoFly

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

UH student earns prestigious award for cancer vaccine research

up-and-comer

Cole Woody, a biology major in the College of Natural Sciences and Mathematics at the University of Houston, has been awarded a Barry Goldwater Scholarship, becoming the first sophomore in UH history to earn the prestigious prize for research in natural sciences, mathematics and engineering.

Woody was recognized for his research on developing potential cancer vaccines through chimeric RNAs. The work specifically investigates how a vaccine can more aggressively target cancers.

Woody developed the MHCole Pipeline, a bioinformatic tool that predicts peptide-HLA binding affinities with nearly 100 percent improvement in data processing efficiency. The MHCole Pipeline aims to find cancer-specific targets and develop personalized vaccines. Woody is also a junior research associate at the UH Sequencing Core and works in Dr. Steven Hsesheng Lin’s lab at MD Anderson Cancer Center.

“Cole’s work ethic and dedication are unmatched,” Preethi Gunaratne, director of the UH Sequencing Core and professor of Biology & Biochemistry at NSM, said in a news release. “He consistently worked 60 to 70 hours a week, committing himself to learning new techniques and coding the MHCole pipeline.”

Woody plans to earn his MD-PhD and has been accepted into the Harvard/MIT MD-PhD Early Access to Research Training (HEART) program. According to UH, recipients of the Goldwater Scholarship often go on to win various nationally prestigious awards.

"Cole’s ability to independently design and implement such a transformative tool at such an early stage in his career demonstrates his exceptional technical acumen and creative problem-solving skills, which should go a long way towards a promising career in immuno-oncology,” Gunaratne added in the release.

Houston founder on shaping the future of medicine through biotechnology and resilience

Guest Column

Living with chronic disease has shaped my life in profound ways. My journey began in 5th grade when I was diagnosed with Scheuermann’s disease, a degenerative disc condition that kept me sidelined for an entire year. Later, I was diagnosed with hereditary neuropathy with liability to pressure palsies (HNPP), a condition that significantly impacts nerve recovery. These experiences didn’t just challenge me physically, they reshaped my perspective on healthcare — and ultimately set me on my path to entrepreneurship. What started as personal health struggles evolved into a mission to transform patient care through innovative biotechnology.

A defining part of living with these conditions was the diagnostic process. I underwent nerve tests that involved electrical shocks to my hands and arms — without anesthesia — to measure nerve activity. The pain was intense, and each test left me thinking: There has to be a better way. Even in those difficult moments, I found myself thinking about how to improve the tools and processes used in healthcare.

HNPP, in particular, has been a frustrating condition. For most people, sleeping on an arm might cause temporary numbness that disappears in an hour. For me, that same numbness can last six months. Even more debilitating is the loss of strength and fine motor skills. Living with this reality forced me to take an active role in understanding my health and seeking solutions, a mindset that would later shape my approach to leadership.

Growing up in Houston, I was surrounded by innovation. My grandfather, a pioneering urologist, was among the first to introduce kidney dialysis in the city in the 1950s. His dedication to advancing patient care initially inspired me to pursue medicine. Though my path eventually led me to healthcare administration and eventually biotech, his influence instilled in me a lifelong commitment to medicine and making a difference.

Houston’s thriving medical and entrepreneurial ecosystems played a critical role in my journey. The city’s culture of innovation and collaboration provided opportunities to explore solutions to unmet medical needs. When I transitioned from healthcare administration to founding biotech companies, I drew on the same resilience I had developed while managing my own health challenges.

My experience with chronic disease also shaped my leadership philosophy. Rather than accepting diagnoses passively, I took a proactive approach questioning assumptions, collaborating with experts, and seeking new solutions. These same principles now guide decision-making at FibroBiologics, where we are committed to developing groundbreaking therapies that go beyond symptom management to address the root causes of disease.

The resilience I built through my health struggles has been invaluable in navigating business challenges. While my early career in healthcare administration provided industry insights, launching and leading companies required the same determination I had relied on in my personal health journey.

I believe the future of healthcare lies in curative treatments, not just symptom management. Fibroblast cells hold the promise of engaging the body’s own healing processes — the most powerful cure for chronic diseases. Cell therapy represents both a scientific breakthrough and a significant business opportunity, one that has the potential to improve patient outcomes while reducing long-term healthcare costs.

Innovation in medicine isn’t just about technology; it’s about reimagining what’s possible. The future of healthcare is being written today. At FibroBiologics, our mission is driven by more than just financial success. We are focused on making a meaningful impact on patients’ lives, and this purpose-driven approach helps attract talent, engage stakeholders, and differentiate in the marketplace. Aligning business goals with patient needs isn’t just the right thing to do, it’s a powerful model for sustainable growth and lasting innovation in biotech.

---

Pete O’Heeron is the CEO and founder of FibroBiologics, a Houston-based regenerative medicine company.


Houston researchers make headway on affordable, sustainable sodium-ion battery

Energy Solutions

A new study by researchers from Rice University’s Department of Materials Science and NanoEngineering, Baylor University and the Indian Institute of Science Education and Research Thiruvananthapuram has introduced a solution that could help develop more affordable and sustainable sodium-ion batteries.

The findings were recently published in the journal Advanced Functional Materials.

The team worked with tiny cone- and disc-shaped carbon materials from oil and gas industry byproducts with a pure graphitic structure. The forms allow for more efficient energy storage with larger sodium and potassium ions, which is a challenge for anodes in battery research. Sodium and potassium are more widely available and cheaper than lithium.

“For years, we’ve known that sodium and potassium are attractive alternatives to lithium,” Pulickel Ajayan, the Benjamin M. and Mary Greenwood Anderson Professor of Engineering at Rice, said in a news release. “But the challenge has always been finding carbon-based anode materials that can store these larger ions efficiently.”

Lithium-ion batteries traditionally rely on graphite as an anode material. However, traditional graphite structures cannot efficiently store sodium or potassium energy, since the atoms are too big and interactions become too complex to slide in and out of graphite’s layers. The cone and disc structures “offer curvature and spacing that welcome sodium and potassium ions without the need for chemical doping (the process of intentionally adding small amounts of specific atoms or molecules to change its properties) or other artificial modifications,” according to the study.

“This is one of the first clear demonstrations of sodium-ion intercalation in pure graphitic materials with such stability,” Atin Pramanik, first author of the study and a postdoctoral associate in Ajayan’s lab, said in the release. “It challenges the belief that pure graphite can’t work with sodium.”

In lab tests, the carbon cones and discs stored about 230 milliamp-hours of charge per gram (mAh/g) by using sodium ions. They still held 151 mAh/g even after 2,000 fast charging cycles. They also worked with potassium-ion batteries.

“We believe this discovery opens up a new design space for battery anodes,” Ajayan added in the release. “Instead of changing the chemistry, we’re changing the shape, and that’s proving to be just as interesting.”

---

This story originally appeared on EnergyCapitalHTX.com.

View All Listings